A PERCUTANEOUS ABSORPTION COMPOSITION
「A PERCUTANEOUS ABSORPTION COMPOSITION」对应一条老挝专利公开记录,由 MEDRX CO., LTD 于 2016-08-29 提交申请,当前状态为已放弃。关键编号与类型标注为 申请号 P/576 / DIP 编号 LAP576 / 主管局代码 LA / 保护类型 Patent - PCT National Phase。时间线要点:公开/公告日 2026-01-23。国际分类 / IPC 标注为 A61K 31/485、A61K 47/12、A61K 9/70、A61P 25/04。发明人 / 设计人包括 AKAZAWA Naoya、HAMAMOTO Hidetoshi、MIWA Yasushi。代理机构 / 代理人记载为 Lao Trademark Agency (LAO IP AGENCY)。公开摘要提示:An object of the present invention is to provide: a percutaneous absorption composition having an improved skin permeability of a basic med…。
This Laos patent “A PERCUTANEOUS ABSORPTION COMPOSITION” is a public DIP intellectual-property record, filed by MEDRX CO., LTD on 2016-08-29; current status: Abandoned. Identifiers include application No. P/576; DIP id LAP576; protection kind Patent - PCT National Phase. Key dates: publication 2026-01-23. Classification: A61K 31/485、A61K 47/12、A61K 9/70、A61P 25/04. Inventor(s)/designer(s): AKAZAWA Naoya, HAMAMOTO Hidetoshi, MIWA Yasushi. Abstract hint: An object of the present invention is to provide: a percutaneous absorption composition having an improved skin permeability of a basic med…. This prose is informational only and does not constitute legal advice, ownership proof or an infringement opinion.
ໜ້ານີ້ສະຫຼຸບ ສິດທິບັດ «A PERCUTANEOUS ABSORPTION COMPOSITION» ຈາກຂໍ້ມູນຈົດທະບຽນເປີດ, ຍື່ນໂດຍ MEDRX CO., LTD ໃນວັນທີ 2016-08-29; ສະຖານະ ປະຖິ້ມ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/576; ລະຫັດ DIP LAP576; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2026-01-23. ປະເພດ/ຫ້ອງ: A61K 31/485、A61K 47/12、A61K 9/70、A61P 25/04. ນັກປະດິດ/ນັກອອກແບບ: AKAZAWA Naoya, HAMAMOTO Hidetoshi, MIWA Yasushi. ສະຫຼຸບ: An object of the present invention is to provide: a percutaneous absorption composition having an improved skin permeability of a basic med…. ໃຊ້ LaoBiz ເພື່ອເບິ່ງ IP ອື່ນຂອງຜູ້ຍື່ນຄົນດຽວ ຫຼື ໜ້າວິສາຫະກິດທີ່ກ່ຽວຂ້ອງ.
P/576
图样
基础信息
- 类型
- 专利
- 申请号
P/576- 状态
- 已放弃
- 申请人
- MEDRX CO., LTD
- 代理机构
- Lao Trademark Agency (LAO IP AGENCY)
- 申请日期
- 2016-08-29
- 公开/公告日
- 2026-01-23
- 国际分类
- A61K 31/485 · A61K 47/12 · A61K 9/70 · A61P 25/04
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
An object of the present invention is to provide: a percutaneous absorption composition having an improved skin permeability of a basic medicament and an agent for promoting the transdermal absorbability of a basic medicament.
The object can be achieved by the use of a percutaneous absorption composition comprising a basic medicament or a salt thereof and sorbic acid and/or its metal salt.
The concentration of the sorbate component is preferably from 0.5 mole to 2.5 moles per mole of the basic medicament.
Preferably, the composition of the present invention may further comprise an organic basic compound and/or an inorganic basic component.
An object of the present invention is to provide: a percutaneous absorption composition having an improved skin permeability of a basic medicament and an agent for promoting the transdermal absorbability of a basic medicament.
The object can be achieved by the use of a percutaneous absorption composition comprising a basic medicament or a salt thereof and sorbic acid and/or its metal salt.
The concentration of the sorbate component is preferably from 0.5 mole to 2.5 moles per mole of the basic medicament.
Preferably, the composition of the present invention may further comprise an organic basic compound and/or an inorganic basic component.